These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. FDA notifications. Tentative approval for fixed-dose combo abacavir/lamivudine. AIDS Alert; 2009 Feb; 24(2):22. PubMed ID: 19219952 [No Abstract] [Full Text] [Related]
9. Triple nuke therapy--results after one year. TreatmentUpdate; 2001; 12(10):3-4. PubMed ID: 11570063 [No Abstract] [Full Text] [Related]
10. Abacavir arm stopped in clinical trial. James JS AIDS Treat News; 2003 Apr; (390):6-7. PubMed ID: 12739475 [TBL] [Abstract][Full Text] [Related]
11. FDA notifications. Generic abacavir and lamivudine combo approved. AIDS Alert; 2008 Oct; 23(10):115. PubMed ID: 18935685 [No Abstract] [Full Text] [Related]
12. Low-density lipoprotein size and lipoprotein-associated phospholipase A2 in HIV-infected patients switching to abacavir or tenofovir. Saumoy M; Ordoñez-Llanos J; Martínez E; Barragán P; Ribera E; Bonet R; Knobel H; Negredo E; Loncá M; Curran A; Gatell JM; Podzamczer D; Antivir Ther; 2011; 16(4):459-68. PubMed ID: 21685533 [TBL] [Abstract][Full Text] [Related]
13. Less than the sum of its parts: failure of a tenofovir-abacavir-Lamivudine triple-nucleoside regimen. Kuritzkes DR J Infect Dis; 2005 Dec; 192(11):1867-8. PubMed ID: 16267755 [No Abstract] [Full Text] [Related]
14. Switching to zidovudine plus lamivudine plus abacavir maintains viral suppression in patients with high viral load before antiretroviral therapy: a retrospective clinical cohort analysis. Moyle GJ; Gazzard BG AIDS; 2002 May; 16(7):1086-7. PubMed ID: 11953482 [No Abstract] [Full Text] [Related]
15. FDA notifications. Tentative approval given for combination of abacavir, lamivudine & zidovudine tablets. AIDS Alert; 2009 Sep; 24(9):106. PubMed ID: 19928326 [No Abstract] [Full Text] [Related]
16. Abacavir and lamivudine combination. Somboonwit C; Kurtyka D; Velez AP Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1599-606. PubMed ID: 19929448 [TBL] [Abstract][Full Text] [Related]
17. Abacavir-based therapy does not affect biological mechanisms associated with cardiovascular dysfunction. Martínez E; Larrousse M; Podzamczer D; Pérez I; Gutiérrez F; Loncá M; Barragán P; Deulofeu R; Casamitjana R; Mallolas J; Pich J; Gatell JM; AIDS; 2010 Jan; 24(3):F1-9. PubMed ID: 20009917 [TBL] [Abstract][Full Text] [Related]